DZ BANK/PUT/FRESENIUS MEDICAL CARE/30/0.1/20.09.24 Stock

Warrant

DE000DW7ZM43

Market Closed - Deutsche Boerse AG 15:34:43 2024-07-05 EDT
0.029 EUR -12.12% Intraday chart for DZ BANK/PUT/FRESENIUS MEDICAL CARE/30/0.1/20.09.24
Current month-30.95%
1 month-14.71%
Date Price Change
24-07-05 0.029 -12.12%
24-07-04 0.033 -8.33%
24-07-03 0.036 -7.69%
24-07-02 0.039 +2.63%
24-07-01 0.038 -9.52%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 03:34 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
Issuer DZ BANK
WKN DW7ZM4
ISINDE000DW7ZM43
Date issued 2022-11-25
Strike 30
Maturity 2024-09-20 (76 Days)
Parity 10 : 1
Emission price 0.67
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.64
Lowest since issue 0.026
Spread 0.02
Spread %40.82%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
36.16 EUR
Average target price
39.97 EUR
Spread / Average Target
+10.55%
Consensus